Bortezomib-lenalidomide-dexamethasone (VRd)

What is Bortezomib-lenalidomide-dexamethasone (VRd)?

Bortezomib-lenalidomide-dexamethasone, also known as VRd, is a regimen that may be used for the treatment of multiple myeloma. It contains the anticancer agents bortezomib and lenalidomide along with dexamethasone, a corticosteroid.

Save up to 80% off your prescriptions!

How do members experience Bortezomib-lenalidomide-dexamethasone (VRd)?

Top 5 reported purposes & perceived effectiveness

Purpose Patients Evaluations Perceived Effectiveness
Multiple myeloma 447 32

Common side effects

Side effect Patients Percentage
Fatigue 10
Constipation 5
Diarrhea 4
Neuropathy in feet 3
Nerve pain (neuralgia) 2
Peripheral neuropathy 2

Side effect severity

Side effects as an overall problem
Severity Evaluations Percentage
Severe 2
Moderate 14
Mild 15
None 1
Learn more about our community’s experience with Bortezomib-lenalidomide-dexamethasone (VRd)

What are people saying about Bortezomib-lenalidomide-dexamethasone (VRd)?

487

487

members have reported taking Bortezomib-lenalidomide-dexamethasone (VRd)

Join the conversation and connect with people who have taken Bortezomib-lenalidomide-dexamethasone (VRd)
Last updated:

Save up to 80% off your prescriptions!